Colgate-Palmolive Q2‘26 Earnings Review: In-line results, unchanged mid-to-long term forecasts.

Research evidence excerpt

Colgate-Palmolive Q2‘26 Earnings Review: In-line results, unchanged mid-to-long term forecasts.

31 July 2026

Estimate Change

Cristian Rios

+1 917 344 8615

U.S. Beverages, Household & Personal Care Products cristian.rios@bernsteinsg.com

Colgate-Palmolive Co Yolanda Zhang

+1 917 344 8346

Rating yolanda.zhang@bernsteinsg.com

Market-Perform

Price Target

CL 99.00 USD (96.00 OLD)

Colgate-Palmolive Q2'26 Earnings Review: In-line results,

unchanged mid-to-long term forecasts.

CL reported a largely in-line F2Q26 result. Core EPS of $0.99 came in ahead of the $0.95

Close Date 31 Jul 2026

consensus. Organic Growth was in line at 2.4%, driven by volume up 0.8% (vs consensus

CL Close Price (USD) 91.30

0.7%) and price up 1.6% (vs consensus 1.8%). Top line YoY growth of 4.9% was modestly

Price Target (USD) 99.00

ahead of 4.7% consensus, and adj net income margin of 14.9% was ahead of14.2%

Upside/(Downside) 8%

consensus. The company largely maintained its FY26 guidance on Organic Sales Growth and

52-Week Range 99.33/74.55

Net Sales Growth, while adjusted Core EPS guidance to MSD from low-to-mid single digit

SPX 7,437.63

previously. The stock closed at $91.27, down -0.36% on the day.

FYE Dec

Growth was primarily driven by Emerging Markets, with Asia Pacific being the standout, Div Yield 2.3%

delivering organic growth 5.2% and outperforming consensus of 2.4%. North America Market Cap (USD) (M) 72,782

was the biggest disappointment, delivering -3.0% organic growth vs consensus of -1.1%. EV (USD) (M) 79,677

We believe that, like for P&G, a complex media landscape could be obstructing storytelling Performance YTD 1M 6M 12M

efforts, as advertising costs rise while market share declines in North America. We see future Absolute (%) 15.5 (0.4) 1.1 8.9

innovation as “business as usual” vs.